KALOS and LOGOS trials with 4,400 patients showed Breztri improved lung function over dual ICS/LABA therapies. No new safety concerns were found in Breztri Phase 3 asthma trials; all primary ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

A Medicaid policy change left fewer kids with access to an asthma inhaler Children were more likely to have no asthma inhaler after GlaxoSmithKline withdrew Flovent from the market GSK withdrew ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. The pharma company continued to sell a chemically ...

GSK withdrew the inhaler after a policy change exposed the company to higher Medicaid rebate costs WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to ...

GSK withdrew the inhaler after a policy change exposed the company to higher Medicaid rebate costs WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to control ...